Diagnosis and Treatment of Atrial Fibrillation
Authors:
- 15 September 2016
- journal article
- research article
- Vol. 94 (6) , 442-452
Abstract
Atrial fibrillation is a supraventricular arrhythmia that adversely affects cardiac function and increases the risk of stroke. It is the most common arrhythmia and a major source of morbidity and mortality; its prevalence increases with age. Pulse rate is sensitive, but not specific, for diagnosis, and suspected atrial fibrillation should be confirmed with 12-lead electrocardiography. Because normal electrocardiographic findings do not rule out atrial fibrillation, home monitoring is recommended if there is clinical suspicion of arrhythmia despite normal test results. Treatment is based on decisions made regarding when to convert to normal sinus rhythm vs. when to treat with rate control, and, in either case, how to best reduce the risk of stroke. For most patients, rate control is preferred to rhythm control. Ablation therapy is used to destroy abnormal foci responsible for atrial fibrillation. Anticoagulation reduces the risk of stroke while increasing the risk of bleeding. The CHA(2)DS(2)-VASc scoring system assesses the risk of stroke, with a score of 2 or greater indicating a need for anticoagulation. The HAS-BLED score estimates the risk of bleeding. Scores of 3 or greater indicate high risk. Warfarin, dabigatran, factor Xa inhibitors (e.g., rivaroxaban, apixaban, edoxaban), and aspirin are options for stroke prevention. Selection of therapy should be individualized based on risks and potential benefits, cost, and patient preference. Left atrial appendage obliteration is an option for reducing stroke risk. Two implantable devices used to occlude the appendage, the Watchman and the Amplatzer Cardiac Plug, appear to be as effective as warfarin in preventing stroke, but they are invasive. Another percutaneous approach to occlusion, wherein the left atrium is closed off using the Lariat, is also available, but data on its long-term effectiveness and safety are still limited. Surgical treatments for atrial fibrillation are reserved for patients who are undergoing cardiac surgery for other reasons. (Copyright (C) 2016 American Academy of Family Physicians.)Keywords
This publication has 39 references indexed in Scilit:
- New Oral Anticoagulants and the Risk of Intracranial HemorrhageJAMA Neurology, 2013
- Impact of the CHA2DS2-VASc Score on Anticoagulation Recommendations for Atrial FibrillationThe American Journal of Medicine, 2012
- A New Risk Scheme to Predict Warfarin-Associated HemorrhageJACC, 2011
- Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial FibrillationThe American Journal of Medicine, 2011
- Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksCochrane Database of Systematic Reviews, 2007
- Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial FibrillationJACC, 2007
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006
- Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacksCochrane Database of Systematic Reviews, 2005
- The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyJACC, 2004
- Effect of rate or rhythm control on quality of life in persistent atrial fibrillationJACC, 2004